Remarkably, DCs sorted from MIP treated group did not suppress tumor-antigen specific T cell proliferation induced by the immunocompetent BMDCs as there was 60% - 80% increase in the frequency of tumor antigen specific T cells in the later generations of cell division (generation 5 and 6) compared to the control group. This evidence concerns the gene MIP and neoplasm.